DAFNA Capital Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $34.5M | Buy |
415,505
+11,000
| +3% | +$912K | 9.51% | 1 |
|
|
2025
Q1 | $32.8M | Buy |
404,505
+7,000
| +2% | +$568K | 9.3% | 1 |
|
|
2024
Q4 | $35.8M | Sell |
397,505
-4,000
| -1% | -$360K | 9.1% | 1 |
|
|
2024
Q3 | $39.7M | Sell |
401,505
-43,500
| -10% | -$4.3M | 9.37% | 1 |
|
|
2024
Q2 | $41.3M | Buy |
445,005
+13,790
| +3% | +$1.28M | 9.86% | 1 |
|
|
2024
Q1 | $40.9M | Sell |
431,215
-52,785
| -11% | -$5.01M | 9.31% | 1 |
|
|
2023
Q4 | $43.2M | Sell |
484,000
-81,000
| -14% | -$7.23M | 10.36% | 1 |
|
|
2023
Q3 | $41.3M | Hold |
565,000
| – | – | 12.83% | 1 |
|
|
2023
Q2 | $47M | Sell |
565,000
-5,000
| -0.9% | -$416K | 12.85% | 1 |
|
|
2023
Q1 | $43.4M | Buy |
570,000
+4,000
| +0.7% | +$305K | 13.02% | 1 |
|
|
2022
Q4 | $47M | Hold |
566,000
| – | – | 13.23% | 1 |
|
|
2022
Q3 | $44.9M | Sell |
566,000
-47,000
| -8% | -$3.73M | 12.07% | 1 |
|
|
2022
Q2 | $45.5M | Buy |
613,000
+343,500
| +127% | +$25.5M | 12.41% | 1 |
|
|
2022
Q1 | $24.2M | Buy |
+269,500
| New | +$24.2M | 6.31% | 2 |
|